They want the look. Why aren’t they booking?

Wild Wisdom is conversion intelligence for medical aesthetics. Its Decisions product helps an operator determine which of three competing constraints should govern the next operating decision on one treatment line: demand, where not enough appropriate demand is reaching the line; conversion, where appropriate patients reach the consultation but clinician-approved plans do not progress through booking, completed treatment and continuation as expected; or deliverable capacity, where demand exists but qualified provider, device, room and time combinations cannot deliver enough appropriate treatment. Wild Wisdom does not assume one of these is the problem. It evaluates them, explains why, states what would change its conclusion, tests an intervention where one is warranted, and closes the decision as continue, change or stop.

Operations leaders — a COO, practice manager, or owner of a clinic or multi-location group — facing a consequential decision on one treatment line, usually a device-led line with a capital cost already sunk. It suits an operator who has the reporting and still cannot say whether the next dollar should go to demand, to conversion or to delivery capacity. It is not for clinics without a consultation step, not for lead-generation agencies, and not for anyone wanting a system that recommends treatments to patients.

Yes, and it is designed to. Three outputs are legitimate and none of them is a failure: no intervention, where the read does not warrant one; insufficient evidence, where too few eligible consultations or too short a window cannot separate the candidates; and a finding that another constraint is binding, where conversion is below the rate you compare against but is not what holds the line back. A product that can only ever recommend action is a product that cannot tell you to leave a line alone, and leaving a line alone is frequently the correct decision.

That is the question Wild Wisdom answers for one treatment line at one location. Marketing analytics measure leads and consultations, a booking system holds appointments, an EMR holds what was done, and a BI or analytics platform can report all three side by side — but reporting three numbers is not the same as arbitrating between them, and a conversion rate below the rate you compare against does not establish that conversion is the constraint that binds. Wild Wisdom reconciles a baseline of at least twelve complete weeks of buyer-approved aggregates, reads the three candidates against the same period, names which one binds and which do not, and publishes the figure that would have to move for that reading to change. Where the answer is demand or deliverable capacity, no conversion intervention is recommended and none is run.

Conversion intelligence is the record and analysis of why patient intent does or does not become a completed treatment. In medical aesthetics most patients who consult already want the outcome; they hesitate over treatment ambiguity, outcome uncertainty, trust, sales pressure, affordability, downtime, provider fit, or they complete one session and never continue. Conversion intelligence makes those reasons measurable at the level of one patient journey, connects them to booking, treatment, continuation and unused capacity, and gives an operator a way to test what to change. It also establishes whether conversion is the constraint that should govern the next decision at all: the same evidence is used to read demand and deliverable capacity against the same period, so a conversion answer is a conclusion rather than an assumption, and a demand or capacity answer is an equally valid result.

Perishable treatment capacity is a treatment opportunity that permanently loses its revenue potential when the available provider, room or device time passes unused. The difference between the capacity a clinic can feasibly deliver and the demand expected to complete in a defined period is its capacity gap, and that gap is what Wild Wisdom helps Operations assess.

Compare tools by the work your clinic needs them to perform, not by category name; features overlap, and an existing system may already meet the need. An EMR or practice-management system holds the clinical record and what was done; a CRM or marketing automation manages contacts and messages; booking software holds appointments; a treatment recommender proposes a treatment; marketing analytics measure leads to consultations; a BI or analytics platform unifies those sources and reports them, increasingly with an assistant that answers questions about them. Wild Wisdom should be evaluated for a different job: arbitrating which of demand, conversion or deliverable capacity should govern the next decision on one treatment line, recording what the patient said was in the way beside the clinician's own recommendation and what happened next, stating what would change that conclusion, and closing the decision as continue, change or stop with the record sealed and append-only. Reporting three numbers and choosing between them are different jobs; an analytics platform can be the source of the aggregates Wild Wisdom reads. It does not replace appointment booking or message delivery, and it never generates a clinical recommendation, a predicted result or a confidence score. Its public demonstration is synthetic and is not comparative performance evidence.

It is Wild Wisdom's engagement, and the only one: one treatment line, one primary location, one consequential decision. It is bought before a consequential commitment of marketing spend, treatment rollout, staffing, capacity or equipment, to establish which constraint should govern that commitment. First the baseline: at least twelve complete weeks of buyer-approved aggregate evidence, reconciled, with any disagreement against the clinic's own systems recorded. Then the constraint read: demand, conversion and deliverable capacity assessed against the same period, with what is known, what the evidence does not tell you, and what would change the conclusion stated together. Then, only if a measured test is warranted, a measurement period defined as part of the investigation — and where conversion binds and the stated friction has a response the clinician has already approved, one is tested: a Decision Story, Outcome Confidence or Flex Access, with each journey followed through booking, treatment and continuation. Where demand or deliverable capacity binds, no intervention is recommended and none is run. Differences between groups are described rather than tested and no causal claim is made. It closes with an executive decision record and a decision: continue, change or stop, with the constraint and the retest trigger stated. No intervention, and insufficient evidence, are legitimate outcomes rather than failures.

On the operating side, from buyer-approved aggregates: consultations attended, clinician-approved plans, treatments booked, treatments completed, continuation, and the deliverable, booked and completed treatment minutes that make a capacity reading possible. On the patient side, where conversion is implicated and only for consultations a clinician has already recommended: what the patient hoped for, what they said was in the way from a fixed set of eight reasons, how confident they felt about deciding before and after, what their provider recorded, and what they decided. It does not measure clinical appropriateness, and it does not score a patient. A clinical decline is recorded as a clinical decision and is never counted as a lost conversion.

No. No integration with an EMR, CRM or booking system is required for the initial engagement. It works from agreed operating exports and current booking and capacity totals supplied by the clinic, with aggregate updates during any measured test period. No patient names or contact details are required at any point; a live pilot’s Decision Room answers and outcome photographs require agreed safeguards before any real record is accepted.

No. Wild Wisdom supplies decision support. The clinic retains control of eligibility, pricing, outreach, bookings and treatment delivery, and every recommended action is approved by your team before anything happens.

By separating the capacity likely to fill naturally from the capacity likely to expire, and by sizing any response to the smaller of the two. A minimum effective release is the smallest controlled quantity of capacity made available through an approved intervention to address an expected gap. A stop threshold is the point at which further intervention may create more discount leakage or displaced full-price demand than additional contribution. Discounting is not required; the clinic sets every commercial term.

No. The clinician determines clinical appropriateness and records their recommendation in their own words. Wild Wisdom shows the patient what their provider recorded, and never generates a recommendation, a predicted result or a confidence score.